Sleep quality and its relation to anthropometric and metabolic factors in overweight/obese patients with non-alcoholic fatty liver disease: a case-control study

睡眠质量及其与超重/肥胖非酒精性脂肪肝患者的人体测量学和代谢因素的关系:一项病例对照研究

阅读:1

Abstract

OBJECTIVE: To investigate whether poor sleep quality could predict non-alcoholic fatty liver disease (NAFLD). RESULTS: In this case-control study, sleep duration and quality were assessed in 72 overweight or obese patients with newly diagnosed NAFLD as "cases" compared with 72 age-and sex-matched adults without NAFLD as "controls". Weight, height, and the circumferences of the waist, hip, and neck, as well as metabolic (glycemia, lipid profile, liver function biomarkers) and hematological factors (complete blood cell count), were assessed. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), and the global PSQI score was classified into good sleep quality (< 6) and low sleep quality (≥ 6). Cases showed significantly greater body mass index (BMI), waist circumference, and waist-to-height ratio as well as serum levels of glucose, hemoglobin A1c, triglyceride, total cholesterol, low-density lipoprotein cholesterol, alanine and aspartate aminotransferases, and 25(OH)D than controls (p < 0.05). The PSQI score was significantly correlated with serum levels of high-density lipoprotein cholesterol, total iron-binding capacity, and 25(OD in patients with NAFLD. Although age and BMI were more likely to be associated with NAFLD (p = 0.042 and p < 0.001, respectively), no association was found for PSQI score as well as its components in NAFLD odds, after adjusting for the confounders.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。